These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Risk of malignancy in focal thyroid lesions identified by (18)F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography: evidence from a large series of studies.
    Author: Qu N, Zhang L, Lu ZW, Wei WJ, Zhang Y, Ji QH.
    Journal: Tumour Biol; 2014 Jun; 35(6):6139-47. PubMed ID: 24622887.
    Abstract:
    Focal thyroid incidentaloma identified on (18)F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography ((18)F-FDG PET or PET/CT) indicates a high risk of thyroid malignancy. A meta-analysis was performed to investigate whether the maximum standardized uptake value (SUVmax) could discriminate between benign and malignant tissues in focal lesions and to explore the cutoff value of SUVmax for the diagnosis of malignancy. A total of 29 studies were involved in this meta-analysis. The results indicated that there was no statistically significant difference in the size of the two benign and malignant groups when measured by ultrasonography (95 % confidence interval (CI), -0.79 to 0.03 min; p=0.07), while a significantly higher focal SUVmax was observed in the malignant group (95 % CI, 0.34 to 1.05; p=0.0001). In conclusion, the findings of this meta-analysis suggest that a higher focal (18)F-FDG SUVmax was associated with a higher risk of thyroid malignancy, especially at a threshold of 3.3 or more.
    [Abstract] [Full Text] [Related] [New Search]